Supernus Pharmaceuticals Inc (SUPN) Stock Price Today & Analysis
SUPN
Valuation
Market cap$2.87B
Price-to-sales ratio4.23
Price-to-book value2.75
Price-earnings ratio-150.80
Return on Equity-2.00%
Return on SalesN/A
Return on AssetsN/A
PEG ratioN/A
Earnings Per Share
Earnings Per Share$-0.33
Income Statement
Average volume635,474
EBITDA$64.66M
1 year high (52w)$57.65
1 year low (52w)$29.16
Dividend
Dividend yield0.00%
Solvency
Debt-to-equity ratioN/A
About Supernus Pharmaceuticals Inc
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
FAQ
You can easily purchase Supernus Pharmaceuticals Inc (SUPN) shares through the Gotrade app. Simply download the app, set up your account, fund it, and then search for the 'SUPN' ticker to begin your investment journey.
At Gotrade, you can kickstart your investment in Supernus Pharmaceuticals Inc with as little as $1.
Absolutely. Brokerage services on Gotrade Indonesia are provided by PT Valbury Asia Futures, a licensed futures and commodities broker registered with and supervised by the Indonesian Financial Services Authority (OJK).
Yes. Gotrade provides access to U.S. stocks from Indonesia through fully backed shares. This is facilitated through a cross-border order routing scheme for foreign stock derivative contracts (PALN), in accordance with regulations from Bappebti (the Commodity Futures Trading Regulatory Agency).
When you trade, you enter into a contract with PT Valbury Asia Futures (Valbury), a Bappebti-registered broker in Indonesia. Valbury, in turn, fully backs its contracts 1-for-1 with Alpaca Securities LLC, a FINRA-licensed broker-dealer in the United States. For every share (or fraction thereof) you hold on Gotrade, a corresponding share is held by Valbury in a separate, segregated brokerage account at Alpaca Securities LLC.
